IBIO, INC. (IBIO) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $56.00K; Additional Paid in Capital, Common StockUSD $450.97M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-45.00K; Retained Earnings (Accumulated Deficit)USD $-365.27M.
- 2026-03-31: Common Stock, Value, IssuedUSD $35.00K; Additional Paid in Capital, Common StockUSD $432.19M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-21.00K; Retained Earnings (Accumulated Deficit)USD $-354.67M.
- 2025-12-31: Common Stock, Value, IssuedUSD $30.00K; Additional Paid in Capital, Common StockUSD $403.46M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $10.00K; Retained Earnings (Accumulated Deficit)USD $-346.94M.
- 2025-09-30: Common Stock, Value, IssuedUSD $20.00K; Additional Paid in Capital, Common StockUSD $393.98M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-15.00K; Retained Earnings (Accumulated Deficit)USD $-337.94M.
IBIO, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Stock Split USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Preferred Stock, Value, Issued USD | Additional Paid in Capital USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Other USD | Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD | Noncontrolling Interest, Increase from Business Combination USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $56.00K | $450.97M | $-45.00K | $-365.27M | $85.71M | $85.71M | 12 month · $1.37M | (m) | 12 month · $84.54M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $35.00K | $432.19M | $-21.00K | $-354.67M | $77.54M | $77.54M | 3 month · $377.00K | (m) | 3 month · $23.54M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $30.00K | $403.46M | $10.00K | $-346.94M | $56.56M | $56.56M | 3 month · $253.00K | (m) | 3 month · $5.58M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $20.00K | $393.98M | $-15.00K | $-337.94M | $56.04M | $56.04M | 3 month · $323.00K | (m) | 3 month · $46.35M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $19.00K | $347.08M | (m) | $-332.22M | $14.88M | $14.88M | 12 month · $1.53M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $10.00K | $338.43M | (m) | $-327.06M | $11.38M | $11.38M | 3 month · $370.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $9.00K | $336.09M | (m) | $-322.20M | $13.89M | $13.89M | 3 month · $475.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $9.00K | $335.58M | (m) | $-317.84M | $17.75M | $17.75M | 3 month · $415.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $9.00K | $335.16M | (m) | $-313.85M | $21.32M | $21.32M | 12 month · $2.04M | 12 month · $7.00K | 12 month · $3.69M | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $9.00K | $330.92M | (m) | $-306.07M | $24.86M | $24.86M | 3 month · $457.00K | (m) | (m) | (m) | (m) | 3 month · $964.00K | (m) | (m) | (m) |
| 2023-12-31 | $30.00K | $312.06M | (m) | $-302.90M | $9.20M | $9.20M | 3 month · $456.00K | 3 month · $7.00K | (m) | (m) | (m) | 3 month · $872.00K | (m) | (m) | (m) |
| 2023-09-30 | $28.00K | $307.87M | (m) | $-294.69M | $13.21M | $13.21M | 3 month · $765.00K | (m) | (m) | (m) | (m) | 3 month · $87.00K | (m) | (m) | (m) |
| 2023-06-30 | $1.00K | $304.32M | (m) | $-288.94M | $15.38M | $15.38M | 12 month · $4.39M | 12 month · $39.00K | (m) | $0.00 | (m) | 12 month · $636.00K | 12 month · $21.00K | (m) | (m) |
| 2023-03-31 | $16.00K | $300.28M | (m) | $-282.91M | $17.39M | $17.39M | 3 month · $1.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $12.00K | $294.59M | $-167.00K | $-275.61M | $18.82M | $18.82M | 3 month · $1.13M | (m) | (m) | (m) | (m) | 3 month · $636.00K | (m) | (m) | (m) |
| 2022-09-30 | $9.00K | $290.64M | $-223.00K | $-242.06M | $48.37M | $48.37M | 3 month · $1.22M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $9.00K | $287.62M | $-213.00K | $-223.93M | $63.48M | $63.48M | 12 month · $4.38M | (m) | 12 month · $967.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $218.00K | $286.23M | $-194.00K | $-206.88M | $79.38M | $79.38M | 3 month · $1.27M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $218.00K | $284.96M | $-91.00K | $-194.49M | $90.60M | $90.60M | 3 month · $1.10M | (m) | 3 month · $967.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $217.00K | $282.96M | $-64.00K | $-182.57M | $100.54M | $100.53M | 3 month · $821.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $9.00K | $282.27M | $-63.00K | $-173.63M | $108.58M | $108.57M | 12 month · $1.59M | (m) | (m) | (m) | (m) | 12 month · $4.71M | (m) | (m) | (m) |
| 2021-03-31 | $216.00K | $278.44M | $-70.00K | $-173.74M | $104.84M | $104.83M | 3 month · $374.00K | (m) | (m) | (m) | (m) | 3 month · $71.00K | (m) | (m) | (m) |
| 2020-12-31 | $212.00K | $273.26M | $-53.00K | $-166.08M | $107.33M | $107.32M | 3 month · $265.00K | (m) | (m) | (m) | (m) | 3 month · $3.12M | (m) | (m) | (m) |
| 2020-09-30 | $180.00K | $237.87M | $-40.00K | $-157.95M | $80.05M | $80.04M | 3 month · $351.00K | (m) | (m) | (m) | (m) | 3 month · $1.52M | (m) | (m) | (m) |
| 2020-06-30 | $140.00K | $206.93M | $-33.00K | $-150.42M | $56.62M | $56.61M | 12 month · $388.00K | (m) | (m) | (m) | (m) | 12 month · $2.34M | (m) | (m) | (m) |
| 2020-03-31 | $107.00K | $150.77M | $-33.00K | $-146.88M | $3.97M | $3.96M | 3 month · $63.00K | (m) | (m) | (m) | $150.77M | 3 month · $321.00K | (m) | (m) | (m) |
| 2019-12-31 | $55.00K | $135.07M | $-31.00K | $-135.61M | $-511.00K | $-520.00K | 3 month · $37.00K | (m) | (m) | (m) | (m) | 3 month · $60.00K | (m) | (m) | (m) |
| 2019-09-30 | $24.00K | $108.36M | $-32.00K | $-110.28M | $-1.93M | $-1.94M | 3 month · $68.00K | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $20.00K | $108.30M | $-31.00K | $-105.82M | $2.46M | $2.46M | 12 month · $241.00K | (m) | (m) | $0.00 | (m) | 12 month · $159.00K | (m) | (m) | (m) |
| 2019-03-31 | $20.00K | $108.24M | $-31.00K | $-101.32M | $6.91M | $6.90M | 3 month · $49.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $19.00K | $108.19M | $-30.00K | $-97.09M | $11.08M | $11.08M | 3 month · $60.00K 6 month · $133.00K | (m) | (m) | (m) | (m) | 6 month · $159.00K | (m) | (m) | (m) |
| 2018-09-30 | $18.00K | $105.67M | $-31.00K | $-92.63M | $13.03M | $13.03M | 3 month · $73.00K | (m) | (m) | (m) | (m) | 3 month · $159.00K | (m) | (m) | (m) |
| 2018-06-30 | $16.00K | $104.41M | $-30.00K | $-88.23M | $16.17M | $16.16M | 12 month · $770.00K | (m) | (m) | (m) | (m) | 12 month · $1.18M | (m) | 12 month · $1.05M | (m) |
| 2018-03-31 | $116.00K | $87.88M | $-29.00K | $-83.81M | $4.15M | $4.20M | 3 month · $183.00K 9 month · $577.00K | (m) | (m) | $0.00 | (m) | 9 month · $321.00K | (m) | 9 month · $1.05M | (m) |
| 2017-12-31 | $115.00K | $87.57M | $-29.00K | $-79.85M | $7.81M | $7.81M | 3 month · $189.00K 6 month · $394.00K | (m) | (m) | $0.00 | (m) | 6 month · $321.00K | (m) | 6 month · $1.05M | (m) |
| 2017-09-30 | $93.00K | $82.18M | $-29.00K | $-75.95M | $6.29M | $6.29M | 3 month · $205.00K | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $9.00K | $81.06M | $-29.00K | $-72.12M | $8.91M | $8.91M | 12 month · $1.01M | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | 12 month · $0.00 |
| 2017-03-31 | $89.00K | $80.68M | $-29.00K | $-67.79M | $12.95M | $12.95M | 9 month · $713.00K | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | 9 month · $0.00 |
| 2016-12-31 | $89.00K | $67.97M | $-29.00K | $-63.88M | $4.15M | $17.15M | 6 month · $506.00K | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | $89.00K | $67.73M | $-29.00K | $-60.65M | $7.14M | $20.70M | 3 month · $265.00K | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $89.00K | $67.47M | $-29.00K | $-57.59M | $9.94M | $24.04M | 12 month · $1.25M | (m) | (m) | $0.00 | (m) | (m) | (m) | 12 month · $15.00M | (m) |
| 2016-03-31 | $83.00K | $63.13M | $-31.00K | $-54.91M | $8.27M | $22.92M | 9 month · $940.00K | (m) | (m) | $0.00 | (m) | (m) | (m) | 9 month · $15.00M | (m) |
| 2015-12-31 | $77.00K | $59.71M | $-33.00K | $-51.88M | $7.88M | (m) | 6 month · $643.00K | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | $77.00K | $59.40M | $-34.00K | $-49.63M | $9.81M | (m) | 3 month · $329.00K | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $77.00K | $59.01M | $-25.00K | $-47.83M | $11.23M | $11.23M | 12 month · $914.00K | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $74.00K | $56.09M | $-26.00K | $-45.94M | $10.19M | (m) | 9 month · $690.00K | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $72.00K | $53.77M | $-14.00K | $-44.27M | $9.57M | (m) | 6 month · $466.00K | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | $68.00K | $47.99M | $-3.00K | $-42.61M | $5.44M | (m) | 3 month · $253.00K | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | $66.00K | $47.23M | $0.00 | $-41.20M | $6.10M | $6.10M | 12 month · $1.07M | (m) | (m) | $0.00 | (m) | 12 month · $29.00K | 12 month · $71.00K | (m) | (m) |
| 2014-03-31 | $66.00K | $46.99M | (m) | $-40.06M | $7.00M | (m) | 9 month · $835.00K | (m) | (m) | $0.00 | (m) | 9 month · $29.00K | 9 month · $71.00K | (m) | (m) |
| 2013-12-31 | $64.00K | $46.19M | (m) | $-38.78M | $7.95M | (m) | 6 month · $510.00K | (m) | (m) | $0.00 | (m) | 6 month · $29.00K | 6 month · $70.00K | (m) | (m) |
| 2013-09-30 | $57.00K | $42.78M | (m) | $-37.16M | $5.68M | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | $57.00K | $42.55M | (m) | $-37.54M | $5.07M | (m) | 12 month · $1.26M | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | $47.77K | $38.47M | (m) | $-36.22M | $2.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $47.77K | $38.13M | (m) | $-34.46M | $3.72M | (m) | 6 month · $670.40K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | $47.77K | $37.91M | (m) | $-33.39M | $4.57M | (m) | 3 month · $453.60K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | $48.00K | $37.46M | (m) | $-31.34M | $6.17M | (m) | 12 month · $2.61M | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | $47.77K | $36.78M | (m) | $-29.98M | $6.85M | (m) | 9 month · $1.94M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $32.38K | $27.15M | (m) | $-26.88M | $305.48K | (m) | 6 month · $1.32M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | $32.38K | $26.13M | (m) | $-25.28M | $886.10K | (m) | 3 month · $338.29K | (m) | 3 month · $-31.98K | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $32.38K | $25.83M | (m) | $-25.66M | $196.00K | (m) | 12 month · $3.90M | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | $1.08M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |